These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22200536)

  • 21. Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.
    Xu L; Yeudall WA; Yang H
    Acta Biomater; 2017 Jul; 57():251-261. PubMed ID: 28438704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p73 supports cellular growth through c-Jun-dependent AP-1 transactivation.
    Vikhanskaya F; Toh WH; Dulloo I; Wu Q; Boominathan L; Ng HH; Vousden KH; Sabapathy K
    Nat Cell Biol; 2007 Jun; 9(6):698-705. PubMed ID: 17496887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor activity of the tea polyphenol epigallocatechin-3-gallate encapsulated in targeted vesicles after intravenous administration.
    Lemarié F; Chang CW; Blatchford DR; Amor R; Norris G; Tetley L; McConnell G; Dufès C
    Nanomedicine (Lond); 2013 Feb; 8(2):181-92. PubMed ID: 22891867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prodigiosin rescues deficient p53 signaling and antitumor effects via upregulating p73 and disrupting its interaction with mutant p53.
    Hong B; Prabhu VV; Zhang S; van den Heuvel AP; Dicker DT; Kopelovich L; El-Deiry WS
    Cancer Res; 2014 Feb; 74(4):1153-65. PubMed ID: 24247721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control.
    Meier C; Hardtstock P; Joost S; Alla V; Pützer BM
    Cancer Res; 2016 Jan; 76(2):197-205. PubMed ID: 26554827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.
    Patel S; Bui TT; Drake AF; Fraternali F; Nikolova PV
    Biochemistry; 2008 Mar; 47(10):3235-44. PubMed ID: 18260640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines.
    Oshima Y; Sasaki Y; Negishi H; Idogawa M; Toyota M; Yamashita T; Wada T; Nagoya S; Kawaguchi S; Yamashita T; Tokino T
    Cancer Biol Ther; 2007 Jul; 6(7):1058-66. PubMed ID: 17568187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors.
    Dufès C; Keith WN; Bilsland A; Proutski I; Uchegbu IF; Schätzlein AG
    Cancer Res; 2005 Sep; 65(18):8079-84. PubMed ID: 16166279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo.
    Navarro G; Tros de Ilarduya C
    Nanomedicine; 2009 Sep; 5(3):287-97. PubMed ID: 19523431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73gamma in lung cancer.
    Logotheti S; Michalopoulos I; Sideridou M; Daskalos A; Kossida S; Spandidos DA; Field JK; Vojtesek B; Liloglou T; Gorgoulis V; Zoumpourlis V
    FEBS J; 2010 Jul; 277(14):3014-27. PubMed ID: 20528922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo.
    Bell HS; Dufes C; O'Prey J; Crighton D; Bergamaschi D; Lu X; Schätzlein AG; Vousden KH; Ryan KM
    J Clin Invest; 2007 Apr; 117(4):1008-18. PubMed ID: 17347683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73.
    Satija YK; Das S
    Oncogene; 2016 Jan; 35(4):513-27. PubMed ID: 25893286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.
    Johnson J; Lagowski J; Lawson S; Liu Y; Kulesz-Martin M
    Oncogene; 2008 Apr; 27(19):2780-7. PubMed ID: 18026135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The structure and cellular regulation of p73: their implication in anticancer therapy].
    Zawacka-Pankau J; Maleńczyk K; Sznarkowska A
    Postepy Hig Med Dosw (Online); 2010 Feb; 64():78-86. PubMed ID: 20231765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
    Jung YS; Qian Y; Chen X
    J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549.
    He Y; Fan SZ; Jiang YG
    Ai Zheng; 2006 Aug; 25(8):925-32. PubMed ID: 16965670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells.
    Li YF; Zhang HT; Xin L
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1463-1473. PubMed ID: 29858680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p73 expression is regulated by RNPC1, a target of the p53 family, via mRNA stability.
    Yan W; Zhang J; Zhang Y; Jung YS; Chen X
    Mol Cell Biol; 2012 Jul; 32(13):2336-48. PubMed ID: 22508983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential liver gene expression with polypropylenimine dendrimers.
    Schatzlein AG; Zinselmeyer BH; Elouzi A; Dufes C; Chim YT; Roberts CJ; Davies MC; Munro A; Gray AI; Uchegbu IF
    J Control Release; 2005 Jan; 101(1-3):247-58. PubMed ID: 15588909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes.
    Lefkimmiatis K; Caratozzolo MF; Merlo P; D'Erchia AM; Navarro B; Levrero M; Sbisa' E; Tullo A
    Cancer Res; 2009 Nov; 69(22):8563-71. PubMed ID: 19861536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.